| Literature DB >> 35958174 |
Charlotte Guillouet1,2,3, Margot C Riou2,3,4, Lucas T Duong4,5,6, Muriel de La Dure-Molla2,3,7, Benjamin P J Fournier3,4,8.
Abstract
Oral mucosal lesions are common in the pediatric population and, apart from traumatic and tumoral etiologies, they can be symptoms of viral, bacterial, fungal or parasitic diseases. Yet, pediatricians and pediatric dentists find it challenging to reach a diagnosis and provide appropriate care when facing lesions of the masticatory or lining mucosa, of the hard or soft palate, of the tongue or salivary glands. Here, we propose a decision tree for the diagnosis of the most frequent viral, bacterial, and fungal diseases starting from their oral lesions in children. By first focusing on describing the elementary lesion itself before its localization and characteristics, it aims to guide the practitioner toward the diagnosis and any necessary complementary exams. To generate this tool, we conducted a literature review of the childhood viral, bacterial, fungal and parasitic diseases with oral mucosal symptoms. For each of the 42 reported diagnoses-20 viral, 9 bacterial, 5 fungal, and 8 parasitic-we collected the infection mechanism and agent(s), the oral lesions and their description, the associated systemic signs and the incidence/prevalence. In fine, our decision tree indexes the 28 diseases for which epidemiological data was available, mainly in Europe and the United States.Entities:
Keywords: communicable diseases; decision trees; mouth mucosa; oral manifestations; oral medicine; pediatric dentistry
Year: 2022 PMID: 35958174 PMCID: PMC9358008 DOI: 10.3389/fped.2022.937808
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
Figure 1Decision tree.
Epidemiological data in the general population for the 28 diseases included in the decision tree (HPV, human papillomavirus; /, no data available; HHV, human herpesvirus).
|
|
| |
|---|---|---|
| Condyloma acuminata, papilloma and focal epithelial hyperplasia | Oral HPV prevalence: 12.3–48.1% of immunocompetent children ( |
|
| Mumps | 6 cases/100,000 inhabitants in 2017 ( | 3,474/100,000 inhabitants in 2019 ( |
| Cytomegalovirus infection | 0.65% of births ( | >1/3 children infected before 5 years old ( |
| Infectious mononucleosis | 50 cases/100,000 inhabitants per year ( | / |
| Herpetic stomatitis and herpes labialis | HHV1 infection: endemic and global in the world ( | |
| Chickenpox | 8,540 cases/100 000 inhabitants in 2017 ( | 8,297 cases/100,000 inhabitants in 2019 ( |
| Herpes zoster | / | 1/3 of adult population ( |
| Hand-foot-and-mouth disease and herpangina | / (no mandatory notification: unknown prevalence/incidence in France and the United States) | |
| Molluscum contagiosum | Global endemic, 8.6% in children <16 years old in Spain ( | / |
| Measles | 3.9 cases/100,000 inhabitants in 2019 ( | 1,282 cases/100 000 inhabitants in 2019 ( |
| Erythema infectiosum | Seroprevalence Parvovirus B19: 2–15% of children <5 and 15–60% in 5–19 years old ( | / |
| HIV-1 infection | 0.9/100,000 births in 2018 ( | 31,000 new cases in 2019 (>13 years old) ( |
| Roseola | Seroprevalence HHV6: 100% of general population ( | / |
| Actinomycosis | 5 cases/100,000 inhabitants ( | / |
| Tuberculosis | 10 cases/100,000 inhabitants in 2020 ( | 8,916 cases/100 000 inhabitants in 2019 ( |
| Scarlet fever and bacterial tonsillitis | / ( | |
| Syphilis | 1,762 cases in 2018 ( | 38,992 new primary and secondary cases 2019 ( |
| Erythema multiforme | Prevalence <1% ( | |
| Mucormycosis | 0.08 cases/100,000 inhabitants in 2010 ( | |
| Primary and invasive aspergillosis | 1.8 cases/100,000 inhabitants ( | 15,000 hospitalizations in 2014 ( |
| Erythematous and pseudomembranous candidiasis | 0.01–3.7% of children ( | / |
| Toxoplasmosis | 200,000–300,000 cases per year ( | Seroprevalence: 11% of population > 6 y. old ( |